KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Daily Values

Growth Metrics

Assets (QoQ)Assets Growth (1y)Assets Growth (3y)Assets Growth (5y)Capital Expenditures (QoQ)Capital Expenditures Growth (1y)Capital Expenditures Growth (3y)Capital Expenditures Growth (5y)Cash & Equivalents (QoQ)Cash & Equivalents Growth (1y)Cash & Equivalents Growth (3y)Cash & Equivalents Growth (5y)Cash from Investing Activities (QoQ)Cash from Investing Activities Growth (1y)Cash from Investing Activities Growth (3y)Cash from Investing Activities Growth (5y)Cash from Operations (QoQ)Cash from Operations Growth (1y)Cash from Operations Growth (3y)Cash from Operations Growth (5y)Dividends Paid - Common (QoQ)Dividends Paid - Common Growth (1y)Dividends Paid - Common Growth (3y)Dividends Paid - Common Growth (5y)Dividends payables (QoQ)Dividends payables Growth (1y)Dividends payables Growth (3y)Dividends payables Growth (5y)EBIT (QoQ)EBIT Growth (1y)EBIT Growth (3y)EBIT Growth (5y)EBIT Margin (QoQ)EBIT Margin Growth (1y)EBIT Margin Growth (3y)EBIT Margin Growth (5y)EBITDA Margin (QoQ)EBITDA Margin Growth (1y)EBITDA Margin Growth (3y)EBITDA Margin Growth (5y)EBT (QoQ)EBT Growth (1y)EBT Growth (3y)EBT Growth (5y)EBT Margin (QoQ)EBT Margin Growth (1y)EBT Margin Growth (3y)EBT Margin Growth (5y)EPS (Basic) (QoQ)EPS (Basic) Growth (1y)EPS (Basic) Growth (3y)EPS (Basic) Growth (5y)EPS (Weighted Average and Diluted) (QoQ)EPS (Weighted Average and Diluted) Growth (1y)EPS (Weighted Average and Diluted) Growth (3y)EPS (Weighted Average and Diluted) Growth (5y)Enterprise Value (QoQ)Enterprise Value Growth (1y)Enterprise Value Growth (3y)Enterprise Value Growth (5y)FCF Margin (QoQ)FCF Margin Growth (1y)FCF Margin Growth (3y)FCF Margin Growth (5y)FCF Payout Ratio (QoQ)FCF Payout Ratio Growth (1y)FCF Payout Ratio Growth (3y)FCF Payout Ratio Growth (5y)Free Cash Flow (QoQ)Free Cash Flow Growth (1y)Free Cash Flow Growth (3y)Free Cash Flow Growth (5y)Gross Margin (QoQ)Gross Margin Growth (1y)Gross Margin Growth (3y)Gross Margin Growth (5y)Gross Profit (QoQ)Gross Profit Growth (1y)Gross Profit Growth (3y)Gross Profit Growth (5y)Net Cash Flow (QoQ)Net Cash Flow Growth (1y)Net Cash Flow Growth (3y)Net Cash Flow Growth (5y)Net Income (QoQ)Net Income Growth (1y)Net Income Growth (3y)Net Income Growth (5y)Net Income towards Common Stockholders (QoQ)Net Income towards Common Stockholders Growth (1y)Net Income towards Common Stockholders Growth (3y)Net Income towards Common Stockholders Growth (5y)Net Margin (QoQ)Net Margin Growth (1y)Net Margin Growth (3y)Net Margin Growth (5y)Operating Income (QoQ)Operating Income Growth (1y)Operating Income Growth (3y)Operating Income Growth (5y)Operating Margin (QoQ)Operating Margin Growth (1y)Operating Margin Growth (3y)Operating Margin Growth (5y)Profit After Tax (QoQ)Profit After Tax Growth (1y)Profit After Tax Growth (3y)Profit After Tax Growth (5y)Property, Plant & Equipment (Net) (QoQ)Property, Plant & Equipment (Net) Growth (1y)Property, Plant & Equipment (Net) Growth (3y)Property, Plant & Equipment (Net) Growth (5y)Return on Assets (QoQ)Return on Assets Growth (1y)Return on Assets Growth (3y)Return on Assets Growth (5y)Return on Capital Employed (QoQ)Return on Capital Employed Growth (1y)Return on Capital Employed Growth (3y)Return on Capital Employed Growth (5y)Return on Equity (QoQ)Return on Equity Growth (1y)Return on Equity Growth (3y)Return on Equity Growth (5y)Return on Invested Capital (QoQ)Return on Invested Capital Growth (1y)Return on Invested Capital Growth (3y)Return on Invested Capital Growth (5y)Return on Sales (QoQ)Return on Sales Growth (1y)Return on Sales Growth (3y)Return on Sales Growth (5y)Revenue (QoQ)Revenue Growth (1y)Revenue Growth (3y)Revenue Growth (5y)Share-based Compensation (QoQ)Share-based Compensation Growth (1y)Share-based Compensation Growth (3y)Share-based Compensation Growth (5y)Shareholder's Equity (QoQ)Shareholder's Equity Growth (1y)Shareholder's Equity Growth (3y)Shareholder's Equity Growth (5y)Tax Rate (QoQ)Tax Rate Growth (1y)Tax Rate Growth (3y)Tax Rate Growth (5y)Total Debt (QoQ)Total Debt Growth (1y)Total Debt Growth (3y)Total Debt Growth (5y)

Pfizer (PFE) Free Cash Flow Growth (1y) (2010 - 2026)

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	FCF Growth (1y) (Qtr)
1	Novartis Ag	107,124,802.25 Bn	107,124,802.25 Bn	-	36.22%
2	Eli Lilly	969.00 Bn	963.72 Bn	16.22 Bn	1,827.56%
3	Johnson & Johnson	539.46 Bn	517.41 Bn	15.96 Bn	-56.64%
4	AbbVie	376.92 Bn	367.57 Bn	10.78 Bn	154.57%
5	Merck	285.00 Bn	279.35 Bn	12.09 Bn	149.74%
6	Amgen	177.58 Bn	165.55 Bn	5.87 Bn	50.71%
7	Gilead Sciences	163.22 Bn	155.50 Bn	5.52 Bn	46.82%
8	Pfizer	145.86 Bn	133.09 Bn	-1.21 Bn	23.04%
9	Bristol Myers Squibb	111.90 Bn	101.44 Bn	8.07 Bn	-55.31%
10	Gsk	88.34 Bn	83.66 Bn	-	-

Historic Data

Download Data 🔒

Date	Value
Mar 29, 2026	23.04%
Sep 28, 2025	-0.74%
Jun 29, 2025	50.37%
Mar 30, 2025	358.81%
Sep 29, 2024	52.34%
Jun 30, 2024	-13.95%
Mar 31, 2024	428.77%
Oct 1, 2023	-85.66%
Jul 2, 2023	-128.60%
Apr 2, 2023	-98.76%
Oct 2, 2022	-27.03%
Jul 3, 2022	-31.06%
Apr 3, 2022	48.04%
Oct 3, 2021	410.68%
Jul 4, 2021	164.03%
Apr 4, 2021	133.53%
Sep 27, 2020	25.50%
Jun 28, 2020	91.18%
Mar 29, 2020	37.80%
Dec 31, 2019	213.59%
Sep 29, 2019	-16.28%
Jun 30, 2019	-37.72%
Mar 31, 2019	-22.48%
Dec 31, 2018	-144.47%
Sep 30, 2018	6.15%
Jul 1, 2018	22.60%
Apr 1, 2018	30.26%
Dec 31, 2017	19.38%
Oct 1, 2017	3.11%
Jul 2, 2017	-12.89%
Apr 2, 2017	-18.65%
Dec 31, 2016	24.84%
Oct 2, 2016	-9.00%
Jul 3, 2016	-16.36%
Apr 3, 2016	241.72%
Dec 31, 2015	-18.27%
Sep 27, 2015	12.97%
Jun 28, 2015	0.60%
Mar 29, 2015	-83.31%
Dec 31, 2014	-1.17%
Sep 28, 2014	-25.51%
Jun 29, 2014	10.47%
Mar 30, 2014	25.80%
Dec 31, 2013	19.15%
Sep 29, 2013	19.16%
Jun 30, 2013	-7.49%
Mar 31, 2013	-16.63%
Dec 31, 2012	-4.48%
Sep 30, 2012	18.39%
Jul 1, 2012	-32.73%
Apr 1, 2012	-42.62%
Dec 31, 2011	-18.35%
Oct 2, 2011	-37.69%
Jul 3, 2011	23.11%
Apr 3, 2011	165.90%
Dec 31, 2010	29.71%
Oct 3, 2010	66.54%
Jul 4, 2010	6.01%
Apr 4, 2010	-330.30%